Cardiff Oncology, Inc. (CRDF)
NASDAQ: CRDF · Real-Time Price · USD
2.500
-0.030 (-1.19%)
At close: Nov 21, 2024, 4:00 PM
2.580
+0.080 (3.20%)
After-hours: Nov 21, 2024, 5:10 PM EST

Cardiff Oncology Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
128666325263510
Upgrade
Market Cap Growth
100.14%5.71%-75.20%-60.31%6519.33%-20.54%
Upgrade
Enterprise Value
72-13-491216002
Upgrade
Last Close Price
2.501.481.406.0117.991.24
Upgrade
PS Ratio
164.48135.50162.04702.511736.3139.24
Upgrade
PB Ratio
2.470.950.591.804.961.31
Upgrade
P/TBV Ratio
2.520.950.591.804.961.31
Upgrade
EV/Sales Ratio
104.44--338.281640.6610.20
Upgrade
Debt / Equity Ratio
0.030.030.030.020.010.24
Upgrade
Asset Turnover
0.010.000.000.000.000.02
Upgrade
Quick Ratio
4.657.1913.5821.5521.462.17
Upgrade
Current Ratio
4.747.4114.2522.2821.792.37
Upgrade
Return on Equity (ROE)
-67.57%-47.07%-31.37%-21.07%-28.50%-188.72%
Upgrade
Return on Assets (ROA)
-38.33%-28.69%-18.77%-12.69%-16.14%-76.48%
Upgrade
Return on Capital (ROIC)
-44.22%-31.37%-19.75%-13.23%-17.28%-109.03%
Upgrade
Earnings Yield
-33.64%-62.67%-61.88%-11.22%-3.04%-170.97%
Upgrade
FCF Yield
-27.11%-47.59%-55.68%-9.22%-2.60%-138.90%
Upgrade
Buyback Yield / Dilution
-1.40%-2.47%-11.71%-86.97%-249.44%-156.37%
Upgrade
Total Shareholder Return
-1.40%-2.47%-11.71%-86.97%-249.44%-156.37%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.